Business · 01/04/2010Updated: 10/17/2026 · 1 min read
FDA Approves New Animal Drug for Otitis Externa in Dogs
Summary
The FDA has approved a new animal drug application filed by Intervet, Inc. for the treatment of otitis externa in dogs, allowing for the veterinary prescription use of a suspension containing orbifloxacin, mometasone furoate monohydrate, and posaconazole.
Original source language: Federal Register — Health and Human ServicesOpen original release →